Search Results

Ryzodeg Offers Improved glycaemic Control With Significantly Lower Rates of Hypoglycaemia Compared to biphasic insulin aspart 30 in Adults With Type 2 Diabetes[1].

• Source: PR Newswire. 2013.

Record details

Insulin degludec/insulin aspart versus biphasic insulin aspart 30 twice daily in insulin-experienced Japanese subjects with uncontrolled type 2 diabetes: Subgroup analysis of a Pan-Asian, treat-to-target Phase 3 Trial 在既往使用胰岛素治疗血糖未得到控制的日本2型糖尿病受试者中比较德谷胰岛素/门冬胰岛素与每日2次双相门冬胰岛素30:泛亚达标治疗3期试验亚组分析

• Authors : Taneda, Shinji; Hyllested‐Winge, Jacob; Gall, Mari‐Anne

Subjects: INSULIN aspart; TYPE 2 diabetes treatment; BIPHASIC insulinJAPAN

• Source: Journal of Diabetes; Mar2017, Vol. 9 Issue 3, p243-247, 1p

Record details

Influence of BMI, Age and Duration of Diabetes Mellitus on Glycaemic Control with Twice-Daily Injections of Biphasic Insulin Aspart 30 versus Multiple Daily Injections of Insulin Aspart (JDDM 18): Retrospective Reanalysis of a 6-Month, Randomized, Open-Label, Multicentre Trial in Japan

• Authors : Arai, K.; Hirao, K.; Yamauchi, M.

Subjects: BODY mass index; GLYCEMIC index; PEOPLE with diabetesJAPAN

• Source: Clinical Drug Investigation; 2010, Vol. 30 Issue 1, p35-40, 6p, 1 Graph

Record details

Insulin lispro 25/75 and insulin lispro 50/50 as starter insulin in Japanese patients with type 2 diabetes: subanalysis of the CLASSIFY randomized trial.

• Authors : Watada H; Department of Metabolism and Endocrinology, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Imori M

Subjects: Biphasic Insulins/Biphasic Insulins/Biphasic Insulins/*therapeutic use ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Hyperglycemia/Hyperglycemia/Hyperglycemia/*prevention & control

• Source: Endocrine journal [Endocr J] 2017 Jul 28; Vol. 64 (7), pp. 705-717. Date of Electronic Publication: 2017 May 24.Publisher: Japan Endocrine Society Country of Publication: Japan NLM ID: 9313485 Publication Model:

Record details

Therapy-Related Satisfaction and Quality of Life for Japanese People with Diabetes Using Rapid-Acting Insulin Analogs: A Web-Based Survey.

• Authors : Ishii, Hitoshi; Maeda, Yasutaka; Sato, Manaka

Subjects: INSULIN derivatives; PEOPLE with diabetes; JAPANESE peopleJAPAN

• Source: Diabetes Therapy; Jul2024, Vol. 15 Issue 7, p1577-1595, 19p

Record details

Effects of Vildagliptin, a Dipeptidyl Peptidase-4 Inhibitor, on the Parameters of Glucose Metabolism and the Cardio-Ankle Vascular Index in Individuals with Type 2 Diabetes.

• Authors : Nagayama, Daiji; Kawana, Hidetoshi; Watanabe, Yasuhiro

Subjects: CD26 antigen; TYPE 2 diabetes; GLUCOSE metabolismJAPAN

• Source: Journal of Clinical Medicine; Jan2024, Vol. 13 Issue 2, p481, 13p

Record details

Long-Term Safety and Clinical Outcomes with Insulin Degludec/Insulin Aspart Treatment in Japanese Patients with Diabetes: A Real-World, Prospective, Observational Study.

• Authors : Katabami, Takuyuki; Eriksen, Kirsten T.; Yamamoto, Yuiko

Subjects: INSULIN aspart; DRUG efficacy; CLINICAL trialsJAPAN

• Source: Advances in Therapy; Jan2022, Vol. 39 Issue 1, p544-561, 18p

Record details

Pharmacokinetic and pharmacodynamic similarity between SAR341402 insulin aspart and Japan-approved NovoRapid in healthy Japanese subjects.

• Authors : Shiramoto, Masanari; Yoshihara, Tatsuya; Schmider, Wolfgang

Subjects: JAPANESE people; INSULIN aspart; PHARMACOKINETICSJAPAN

• Source: Scientific Reports; 11/25/2021, Vol. 11 Issue 1, p1-7, 7p

Record details

A Real-World, Prospective, Non-interventional Study of Adults with T2D Switching to IDegAsp from Glargine U100 or U300 in Japan.

• Authors : Shigiyama, Fumika; Liu, Lei; Nordahl, Helene

Subjects: INSULIN aspart; GLYCEMIC control; HYPOGLYCEMIAJAPAN

• Source: Diabetes Therapy; Sep2021, Vol. 12 Issue 9, p2405-2421, 17p

Record details

Performance evaluation of case definitions of type 1 diabetes for health insurance claims data in Japan.

• Authors : Okui, Tasuku; Nojiri, Chinatsu; Kimura, Shinichiro

Subjects: HEALTH insurance claims; TYPE 1 diabetes; NOSOLOGYJAPANUNIVERSITY of Colorado Hospital

• Source: BMC Medical Informatics & Decision Making; 2/11/2021, Vol. 21 Issue 1, p1-7, 7p

Record details